Laboratory Bacteriology Research (LBR), Faculty of Medicine & Health Sciences, Universiteit Gent, Ghent, Belgium.
PLoS One. 2013 Nov 29;8(11):e79010. doi: 10.1371/journal.pone.0079010. eCollection 2013.
Cystic Fibrosis (CF) patients are vulnerable to airway colonization with Pseudomonas aeruginosa. In case eradication fails after antibiotic treatment, patients become chronically colonized with P. aeruginosa, with recurrent pulmonary exacerbation, for which patients typically are hospitalized for 2 weeks and receive intravenous antibiotic treatment. Normally, improvement of the patients' health is established.
Determination of the correspondence between patient improvement and changes of the P. aeruginosa and total bacterial load in the sputum.
Eighteen CF patients with exacerbation were included for a total of 27 hospitalization episodes. At day 1, 8 and 15, inflammation and lung function parameters were determined, together with the P. aeruginosa load in the sputum using culture, quantitative PCR (qPCR) and propidium monoazide qPCR.
Patients improved during hospitalization (decrease in levels of C-reactive protein, white blood cell counts and erythrocyte sedimentation rate, increase of FEV1), reaching normal values already after one week. Also the P. aeruginosa load and the total bacterial load decreased during the first week of antibiotic treatment (p<0.05), except for patients with a low lung function (FEV1≤39.4%), for whom no significant decrease of P. aeruginosa was established. Comparison of culture-based and propidium monoazide qPCR-based quantification of P. aeruginosa showed that at the end of the treatment on average 62% of the P. aeruginosa cells are not cultivable, indicating that many cells are alive but dormant, or dead but still structurally intact.
Improvement of the clinical status is accompanied with a decrease of the P. aeruginosa load, whereby both occur mainly during the first week of antibiotic treatment. However, for patients with a low lung function, no decrease of the P. aeruginosa load is observed. Comparison of detection techniques shows that a large amount of noncultivable or dead bacteria are present in the samples.
囊性纤维化 (CF) 患者易发生铜绿假单胞菌气道定植。如果抗生素治疗后未能根除,患者会被铜绿假单胞菌慢性定植,导致反复肺部恶化,患者通常需要住院 2 周并接受静脉内抗生素治疗。通常,患者的健康状况会得到改善。
确定患者改善情况与痰中铜绿假单胞菌和总细菌负荷变化之间的对应关系。
共纳入 18 例 CF 恶化患者,共 27 例住院发作。在第 1、8 和 15 天,测定炎症和肺功能参数,同时使用培养、定量 PCR(qPCR)和吖啶橙 qPCR 测定痰中铜绿假单胞菌负荷。
患者在住院期间(C 反应蛋白、白细胞计数和红细胞沉降率水平降低,FEV1 增加)得到改善,在一周后即达到正常水平。在抗生素治疗的第一周,铜绿假单胞菌负荷和总细菌负荷也降低(p<0.05),但肺功能较低(FEV1≤39.4%)的患者除外,他们没有发现铜绿假单胞菌的显著减少。基于培养的和基于吖啶橙 qPCR 的铜绿假单胞菌定量比较表明,在治疗结束时,平均有 62%的铜绿假单胞菌细胞不可培养,表明许多细胞处于休眠或死亡但仍保持结构完整的状态。
临床状况的改善伴随着铜绿假单胞菌负荷的降低,这主要发生在抗生素治疗的第一周。然而,对于肺功能较低的患者,铜绿假单胞菌负荷没有降低。检测技术的比较表明,样本中存在大量不可培养或死亡的细菌。